MX9601591A - Vehiculos surtidores de farmaco termicamente gelificadores que contienen eteres de celulosa. - Google Patents

Vehiculos surtidores de farmaco termicamente gelificadores que contienen eteres de celulosa.

Info

Publication number
MX9601591A
MX9601591A MX9601591A MX9601591A MX9601591A MX 9601591 A MX9601591 A MX 9601591A MX 9601591 A MX9601591 A MX 9601591A MX 9601591 A MX9601591 A MX 9601591A MX 9601591 A MX9601591 A MX 9601591A
Authority
MX
Mexico
Prior art keywords
drug delivery
cellulose ethers
delivery vehicles
thermally
containing cellulose
Prior art date
Application number
MX9601591A
Other languages
English (en)
Inventor
Bhagwati P Kabra
John C Lang
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of MX9601591A publication Critical patent/MX9601591A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen vehículos surtidores de fármaco que incrementan reversiblemente en cuanto a modulo de pérdida o modulo de almacenamiento o ambos al contacto con los ojos, la piel, membranas mucosas o una cavidad corporal. Los vehículos contienen uno o más éteres de celulosa sustituidos no ionicos y no requieren un agente tensioactivo cargado o un polímero sensible al pH para dicho incremento en cuanto a modulo de pérdida o modulo de almacenamiento o ambos durante la administracion. En una modalidad, el vehículo se gelifica durante la instalacion en los ojos.
MX9601591A 1994-08-30 1995-08-23 Vehiculos surtidores de farmaco termicamente gelificadores que contienen eteres de celulosa. MX9601591A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29824494A 1994-08-30 1994-08-30
PCT/US1995/010877 WO1996006597A1 (en) 1994-08-30 1995-08-23 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers

Publications (1)

Publication Number Publication Date
MX9601591A true MX9601591A (es) 1997-05-31

Family

ID=23149679

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9601591A MX9601591A (es) 1994-08-30 1995-08-23 Vehiculos surtidores de farmaco termicamente gelificadores que contienen eteres de celulosa.

Country Status (15)

Country Link
US (1) US5618800A (es)
EP (1) EP0725628B1 (es)
JP (1) JPH09508143A (es)
CN (1) CN1162148C (es)
AT (1) ATE208186T1 (es)
AU (1) AU686455B2 (es)
CA (1) CA2172373C (es)
DE (1) DE69523733T2 (es)
DK (1) DK0725628T3 (es)
ES (1) ES2162638T3 (es)
HK (1) HK1012558A1 (es)
MX (1) MX9601591A (es)
PT (1) PT725628E (es)
TW (1) TW460288B (es)
WO (1) WO1996006597A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19746264A1 (de) * 1997-10-20 1999-04-29 Wolff Walsrode Ag Verfahren zur Herstellung einer Carboxymethylcellulose mit verbesserter Wasserretention
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
PT1150918E (pt) * 1999-02-03 2005-01-31 Biosante Pharmaceuticals Inc Metodo de fabrico de particulas terapeuticas de fosfato de calcio
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US6235893B1 (en) 1999-04-01 2001-05-22 The Dow Chemical Company Process for making cellulose ether having enhanced gel strength
ATE256705T1 (de) * 1999-04-01 2004-01-15 Dow Global Technologies Inc Methylcellulose mit verbesserter gelfestigkeit
US6932759B2 (en) 1999-06-09 2005-08-23 Gene W. Kammerer Surgical instrument and method for treating female urinary incontinence
US7226407B2 (en) 1999-06-09 2007-06-05 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
CA2376282C (en) 1999-06-09 2008-08-19 Ethicon, Inc. Method and apparatus for adjusting flexible areal polymer implants
US7121997B2 (en) 1999-06-09 2006-10-17 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
AU8008300A (en) 1999-11-01 2001-05-14 Alcon Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
US7097855B1 (en) 2000-01-31 2006-08-29 Massachusetts Institute Of Technology Transdermal thermal polymerization
US7131943B2 (en) 2000-03-09 2006-11-07 Ethicon, Inc. Surgical instrument and method for treating organ prolapse conditions
PL199321B1 (pl) 2000-07-28 2008-09-30 Alcon Inc Kompozycje farmaceutyczne zawierające tobramycynę i gumę ksantanową
US20030060447A1 (en) * 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
WO2002040056A2 (en) 2000-11-06 2002-05-23 Alcon, Inc Carrageenan viscoelastics for ocular surgery
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
WO2004006957A1 (en) * 2002-07-15 2004-01-22 Alcon, Inc. Pharmaceutical compositions for otic use
DE10350248A1 (de) * 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
EP1811941A4 (en) * 2004-11-01 2008-09-10 Biosante Pharmaceuticals Inc CALCIUM PHOSPHATE THERAPEUTIC PARTICLES FOR AESTHETIC OR COSMETIC MEDICINE, AND METHODS OF MAKING AND USING THE SAME
EP1909703A4 (en) 2005-08-04 2011-01-12 Bard Inc C R SYSTEMS AND METHOD FOR BASE IMPLANTS
US8092366B2 (en) 2005-11-14 2012-01-10 C. R. Bard, Inc. Sling anchor system
US20070140897A1 (en) * 2005-12-21 2007-06-21 Hongna Wang Ph stable biguanide composition and method of treatment and prevention of infections
US20070142478A1 (en) * 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
US20070141091A1 (en) * 2005-12-21 2007-06-21 Erning Xia Biguanide ointment and method of treatment and prevention of infections
US8480559B2 (en) 2006-09-13 2013-07-09 C. R. Bard, Inc. Urethral support system
DE102006062140A1 (de) * 2006-12-22 2008-06-26 Dow Wolff Cellulosics Gmbh Celluloseetheradditive für die Extrusion keramischer Massen
US20080161405A1 (en) * 2006-12-29 2008-07-03 Erning Xia Biguanide Composition and Method of Treatment and Prevention of Infections
US8206280B2 (en) 2007-11-13 2012-06-26 C. R. Bard, Inc. Adjustable tissue support member
DE102007059939A1 (de) 2007-12-12 2009-06-18 Müller-Schulte, Detlef, Dr. Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
US8449573B2 (en) 2008-12-05 2013-05-28 Boston Scientific Scimed, Inc. Insertion device and method for delivery of a mesh carrier
US8968334B2 (en) 2009-04-17 2015-03-03 Boston Scientific Scimed, Inc. Apparatus for delivering and anchoring implantable medical devices
US9301750B2 (en) 2009-11-03 2016-04-05 Boston Scientific Scimed, Inc. Device and method for delivery of mesh-based devices
GB201105408D0 (en) * 2011-03-30 2011-05-11 Glaxo Group Ltd Composition
US20160120990A1 (en) * 2013-07-17 2016-05-05 Dow Global Technologies Llc Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
WO2015047762A1 (en) * 2013-09-25 2015-04-02 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether
US20180071209A1 (en) * 2015-03-24 2018-03-15 Dow Global Technologies Llc Aqueous solution of polymers
WO2017024282A1 (en) 2015-08-05 2017-02-09 Children's Medical Center Corporation Compositions with permeation enhancers for drug delivery
CA3036696A1 (en) * 2016-09-14 2018-03-22 Children's Medical Center Corporation Compositions with permeation enhancers for drug delivery

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3767788A (en) * 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
SE403782B (sv) * 1973-03-14 1978-09-04 Mo Och Domsjoe Ab Nonjoniska cellulosaetrar
US4001211A (en) * 1974-12-02 1977-01-04 The Dow Chemical Company Pharmaceutical capsules from improved thermogelling methyl cellulose ethers
CS180191B1 (en) * 1974-12-04 1977-12-30 Arnost Kotik Tube shape heat exchanger with internal ribbing
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3700681A1 (de) * 1987-01-12 1988-07-21 Breveteam Sa Sphaerisches faseraggregat, insbesondere als fuell- oder polstermaterial
SE461396B (sv) * 1988-05-24 1990-02-12 Berol Kemi Ab Saett att vid temperaturhoejning motverka viskositetsnedgaang alternativt aastadkomma viskositetsoekning hos ett vattenbaserat system innehaallande en polymer som viskositetsgivare
US5279660A (en) * 1988-05-24 1994-01-18 Berol Nobel Stenungsund Ab Use of viscosity-adjusting agent to counteract viscosity decrease upon temperature increase of a water-based system
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5306501A (en) * 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5124151A (en) * 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
US5212162A (en) * 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5296228A (en) * 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5470881A (en) * 1993-09-09 1995-11-28 West Virginia University Research Corporation Urea ophthalmic ointment and solution

Also Published As

Publication number Publication date
ATE208186T1 (de) 2001-11-15
WO1996006597A1 (en) 1996-03-07
CN1134662A (zh) 1996-10-30
DE69523733D1 (de) 2001-12-13
AU3496595A (en) 1996-03-22
DK0725628T3 (da) 2001-12-27
CA2172373A1 (en) 1996-03-07
CA2172373C (en) 1999-03-16
DE69523733T2 (de) 2002-08-01
EP0725628A1 (en) 1996-08-14
PT725628E (pt) 2002-03-28
EP0725628B1 (en) 2001-11-07
CN1162148C (zh) 2004-08-18
AU686455B2 (en) 1998-02-05
TW460288B (en) 2001-10-21
US5618800A (en) 1997-04-08
ES2162638T3 (es) 2002-01-01
HK1012558A1 (en) 1999-08-06
JPH09508143A (ja) 1997-08-19

Similar Documents

Publication Publication Date Title
MX9601591A (es) Vehiculos surtidores de farmaco termicamente gelificadores que contienen eteres de celulosa.
TWI262797B (en) Gelling ophthalmic compositions containing xanthan gum
USD295445S (en) Combined punctum plug dilator and inserter for treating dry eye or other ophthalmic ailments
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
AU4718297A (en) Improvements in or relating to diagnostic/therapeutic agents
CA2264895A1 (en) Device and method for treating ophthalmic diseases
TW224428B (es)
GR3036622T3 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
CA2230595A1 (en) Bioresorbable polymer use in cochlear and other implants
EP0718288B8 (fr) Sels liquides hydrophobes, leur préparation et leur application en électrochimie
CA2173755A1 (en) Multi-functional inner ear treatment and diagnostic system
AU1919995A (en) Hingeless intraocular lens microcartridges
CA2304976A1 (en) Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels
AU559597B2 (en) Storage bag
FI914607A0 (fi) Farmaceutisk blandning i gelform i en dispenserfoerpackning.
WO1997005185A3 (en) Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents
CA2308513A1 (en) Method and composition for delivering zinc to the nasal membrane
CA2193543A1 (en) Sodium hyaluronate based ophthalmic formulation for use in eye surgery
AU2002310691A1 (en) Polymeric corneal bandages/lenses for delivery of a pharmaceutical
AU5980200A (en) Ophthalmic compositions in form of aqueous gels
ATE191845T1 (de) Pharmazeutische träger zur topischen ophthalmischen anwendung
CA2305359A1 (en) Drug delivery system
CA2133955A1 (en) Polyetheramidoamine hydrogels as heparinizable materials
WO1995016435A3 (en) Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
CA2323810A1 (en) Ophthalmic solution comprising glycogen